{"count": 9, "results": [{"_id": "33849417", "pmid": 33849417, "title": "Psychological Continuum of Elderly Patients Suffering from Arterial Hypertension with Metabolic Syndrome, Against the Background of Chronotherapy with a Fixed Combination of Amlodipine, Lisinopril and Rosuvastatin.", "journal": "Kardiologiia", "authors": ["Agarkov NM", "Okhotnikov OI", "Korneeva SI", "Moskaleva EO", "Moskalev AA", "Kolomiets VI", "Markelova AM", "Markelova EA"], "date": "2021-03-30T00:00:00Z", "doi": "10.18087/cardio.2021.3.n1509", "meta_date_publication": "2021 Mar 30", "meta_volume": "61", "meta_issue": "3", "meta_pages": "36-41", "score": 50257.176, "text_hl": "Psychological Continuum of Elderly @SPECIES_9606 @@@Patients@@@ Suffering from @DISEASE_Pulmonary_Arterial_Hypertension @DISEASE_MESH:D000081029 @@@Arterial Hypertension@@@ with @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@Metabolic Syndrome@@@, Against the Background of Chronotherapy with a Fixed Combination of @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@Amlodipine@@@, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@Rosuvastatin@@@.", "citations": {"NLM": "Agarkov NM, Okhotnikov OI, Korneeva SI, Moskaleva EO, Moskalev AA, Kolomiets VI, Markelova AM, Markelova EA. Psychological Continuum of Elderly Patients Suffering from Arterial Hypertension with Metabolic Syndrome, Against the Background of Chronotherapy with a Fixed Combination of Amlodipine, Lisinopril and Rosuvastatin. Kardiologiia. 2021 Mar 30;61(3):36-41. PMID: 33849417", "BibTeX": "@article{33849417, title={Psychological Continuum of Elderly Patients Suffering from Arterial Hypertension with Metabolic Syndrome, Against the Background of Chronotherapy with a Fixed Combination of Amlodipine, Lisinopril and Rosuvastatin.}, author={Agarkov NM and Okhotnikov OI and Korneeva SI and Moskaleva EO and Moskalev AA and Kolomiets VI and Markelova AM and Markelova EA}, journal={Kardiologiia}, volume={61}, number={3}, pages={36-41}}"}}, {"_id": "18491582", "pmid": 18491582, "title": "[Efficacy of combined antihypertensive treatment with amlodipine and lisinopril in metabolic syndrome].", "journal": "Ter Arkh", "authors": ["Shevchenko OP", "Praskurnichiĭ EA", "Savel'eva SA"], "date": "2008-01-01T00:00:00Z", "meta_date_publication": "2008", "meta_volume": "80", "meta_issue": "4", "meta_pages": "54-9", "score": 50076.82, "text_hl": "[Efficacy of combined antihypertensive treatment with @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ in @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@metabolic syndrome@@@].", "citations": {"NLM": "Shevchenko OP, Praskurnichiĭ EA, Savel'eva SA. [Efficacy of combined antihypertensive treatment with amlodipine and lisinopril in metabolic syndrome]. Ter Arkh. 2008;80(4):54-9. PMID: 18491582", "BibTeX": "@article{18491582, title={[Efficacy of combined antihypertensive treatment with amlodipine and lisinopril in metabolic syndrome].}, author={Shevchenko OP and Praskurnichiĭ EA and Savel'eva SA}, journal={Ter Arkh}, volume={80}, number={4}, pages={54-9}}"}}, {"_id": "25440999", "pmid": 25440999, "title": "Comparative effect of telmisartan vs lisinopril on blood pressure in patients of metabolic syndrome.", "journal": "Endocr Metab Immune Disord Drug Targets", "authors": ["Gore PN", "Badar VA", "Hardas MM", "Bansode VJ"], "date": "2015-01-01T00:00:00Z", "doi": "10.2174/1871530314666141128154152", "meta_date_publication": "2015", "meta_volume": "15", "meta_issue": "1", "meta_pages": "64-70", "score": 50069.83, "text_hl": "Comparative effect of @CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@telmisartan@@@ vs @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ on blood pressure in @SPECIES_9606 @@@patients@@@ of @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@metabolic syndrome@@@.", "citations": {"NLM": "Gore PN, Badar VA, Hardas MM, Bansode VJ. Comparative effect of telmisartan vs lisinopril on blood pressure in patients of metabolic syndrome. Endocr Metab Immune Disord Drug Targets. 2015;15(1):64-70. PMID: 25440999", "BibTeX": "@article{25440999, title={Comparative effect of telmisartan vs lisinopril on blood pressure in patients of metabolic syndrome.}, author={Gore PN and Badar VA and Hardas MM and Bansode VJ}, journal={Endocr Metab Immune Disord Drug Targets}, volume={15}, number={1}, pages={64-70}}"}}, {"_id": "19105412", "pmid": 19105412, "title": "[Lisinopril: antihypertensive activity, effects on heart rhythm variability and carbohydrate metabolism in patients with metabolic syndrome].", "journal": "Ter Arkh", "authors": ["Shevchenko OP", "Praskurnichiĭ EA", "Savel'eva SA"], "date": "2008-01-01T00:00:00Z", "meta_date_publication": "2008", "meta_volume": "80", "meta_issue": "10", "meta_pages": "37-41", "score": 50066.08, "text_hl": "MATERIAL AND METHODS: Twenty @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@MS@@@ @SPECIES_9606 @@@patients@@@ (13 females and 7 males) received @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ monotherapy for 12 weeks. ", "citations": {"NLM": "Shevchenko OP, Praskurnichiĭ EA, Savel'eva SA. [Lisinopril: antihypertensive activity, effects on heart rhythm variability and carbohydrate metabolism in patients with metabolic syndrome]. Ter Arkh. 2008;80(10):37-41. PMID: 19105412", "BibTeX": "@article{19105412, title={[Lisinopril: antihypertensive activity, effects on heart rhythm variability and carbohydrate metabolism in patients with metabolic syndrome].}, author={Shevchenko OP and Praskurnichiĭ EA and Savel'eva SA}, journal={Ter Arkh}, volume={80}, number={10}, pages={37-41}}"}}, {"_id": "15477769", "pmid": 15477769, "title": "[Effect of moxonidine on parameters of lipid metabolism in patients with metabolic syndrome.].", "journal": "Kardiologiia", "authors": ["Anichkov DA", "Shostak NA"], "date": "2004-01-01T00:00:00Z", "meta_date_publication": "2004", "meta_volume": "44", "meta_issue": "9", "meta_pages": "13-5", "score": 50065.887, "text_hl": "AIM: To compare effects of @CHEMICAL_moxonidine @CHEMICAL_MESH:C043482 @@@moxonidine@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ on parameters of @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ metabolism in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@metabolic syndrome@@@. ", "citations": {"NLM": "Anichkov DA, Shostak NA. [Effect of moxonidine on parameters of lipid metabolism in patients with metabolic syndrome.]. Kardiologiia. 2004;44(9):13-5. PMID: 15477769", "BibTeX": "@article{15477769, title={[Effect of moxonidine on parameters of lipid metabolism in patients with metabolic syndrome.].}, author={Anichkov DA and Shostak NA}, journal={Kardiologiia}, volume={44}, number={9}, pages={13-5}}"}}, {"_id": "18000186", "pmid": 18000186, "title": "Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).", "journal": "Diabetes Care", "authors": ["Black HR", "Davis B", "Barzilay J", "Nwachuku C", "Baimbridge C", "Marginean H", "Wright JT Jr", "Basile J", "Wong ND", "Whelton P", "Dart RA", "Thadani U", "Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial"], "date": "2008-02-01T00:00:00Z", "doi": "10.2337/dc07-1452", "meta_date_publication": "2008 Feb", "meta_volume": "31", "meta_issue": "2", "meta_pages": "353-60", "score": 50060.25, "text_hl": "For those without @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@metabolic syndrome@@@, the rate of newly diagnosed @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ was 7.7% for @CHEMICAL_Chlorthalidone @CHEMICAL_MESH:D002752 @@@chlorthalidone@@@, 4.2% for @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@, and 4.7% for @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (P < 0.05 for both comparisons). ", "citations": {"NLM": "Black HR, Davis B, Barzilay J, Nwachuku C, Baimbridge C, Marginean H, Wright JT Jr, Basile J, Wong ND, Whelton P, Dart RA, Thadani U, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care. 2008 Feb;31(2):353-60. PMID: 18000186", "BibTeX": "@article{18000186, title={Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).}, author={Black HR and Davis B and Barzilay J and Nwachuku C and Baimbridge C and Marginean H and Wright JT Jr and Basile J and Wong ND and Whelton P and Dart RA and Thadani U and Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial}, journal={Diabetes Care}, volume={31}, number={2}, pages={353-60}}"}}, {"_id": "15881482", "pmid": 15881482, "title": "Comparison of rilmenidine and lisinopril on ambulatory blood pressure and plasma lipid and glucose levels in hypertensive women with metabolic syndrome.", "journal": "Curr Med Res Opin", "authors": ["Anichkov DA", "Shostak NA", "Schastnaya OV"], "date": "2005-01-01T00:00:00Z", "doi": "10.1185/030079904x20277", "meta_date_publication": "2005 Jan", "meta_volume": "21", "meta_issue": "1", "meta_pages": "113-9", "score": 50059.93, "text_hl": "CONCLUSION: @CHEMICAL_Rilmenidine @CHEMICAL_MESH:D000077769 @@@Rilmenidine@@@ has similar effects on ambulatory BP patterns in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@women@@@ with @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@metabolic syndrome@@@ as @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@. ", "citations": {"NLM": "Anichkov DA, Shostak NA, Schastnaya OV. Comparison of rilmenidine and lisinopril on ambulatory blood pressure and plasma lipid and glucose levels in hypertensive women with metabolic syndrome. Curr Med Res Opin. 2005 Jan;21(1):113-9. PMID: 15881482", "BibTeX": "@article{15881482, title={Comparison of rilmenidine and lisinopril on ambulatory blood pressure and plasma lipid and glucose levels in hypertensive women with metabolic syndrome.}, author={Anichkov DA and Shostak NA and Schastnaya OV}, journal={Curr Med Res Opin}, volume={21}, number={1}, pages={113-9}}"}}, {"_id": "21155616", "pmid": 21155616, "title": "Effects of manidipine and its combination with an ACE inhibitor on insulin sensitivity and metabolic, inflammatory and prothrombotic markers in hypertensive patients with metabolic syndrome: the MARCADOR study.", "journal": "Clin Drug Investig", "authors": ["Martinez-Martin FJ", "Macias-Batista A", "Comi-Diaz C", "Rodriguez-Rosas H", "Soriano-Perera P", "Pedrianes-Martin P"], "date": "2011-01-01T00:00:00Z", "doi": "10.2165/11587590-000000000-00000", "meta_date_publication": "2011", "meta_volume": "31", "meta_issue": "3", "meta_pages": "201-12", "score": 50058.547, "text_hl": "CONCLUSION: In @SPECIES_9606 @@@patients@@@ with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@metabolic syndrome@@@, @CHEMICAL_manidipine @CHEMICAL_MESH:C054218 @@@manidipine@@@, both alone and in combination with the ACE inhibitor @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, is significantly superior to @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@ for improving @GENE_INS @GENE_3630 @@@insulin@@@ sensitivity as well as several metabolic, @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ and prothrombotic markers. ", "citations": {"NLM": "Martinez-Martin FJ, Macias-Batista A, Comi-Diaz C, Rodriguez-Rosas H, Soriano-Perera P, Pedrianes-Martin P. Effects of manidipine and its combination with an ACE inhibitor on insulin sensitivity and metabolic, inflammatory and prothrombotic markers in hypertensive patients with metabolic syndrome: the MARCADOR study. Clin Drug Investig. 2011;31(3):201-12. PMID: 21155616", "BibTeX": "@article{21155616, title={Effects of manidipine and its combination with an ACE inhibitor on insulin sensitivity and metabolic, inflammatory and prothrombotic markers in hypertensive patients with metabolic syndrome: the MARCADOR study.}, author={Martinez-Martin FJ and Macias-Batista A and Comi-Diaz C and Rodriguez-Rosas H and Soriano-Perera P and Pedrianes-Martin P}, journal={Clin Drug Investig}, volume={31}, number={3}, pages={201-12}}"}}, {"_id": "28294798", "pmid": 28294798, "title": "[Safety and Efficacy of Amlodipine, Lisinopril and Rosuvastatin Therapy in Patients With Metabolic Syndrome and Nonalcoholic Fatty Liver Disease].", "journal": "Kardiologiia", "authors": ["Baranova EI", "Berezina AV", "Melioranskaya EI", "Polyakova EA"], "date": "2015-10-01T00:00:00Z", "doi": "10.18565/cardio.2015.10.68-75", "meta_date_publication": "2015 Oct", "meta_volume": "55", "meta_issue": "10", "meta_pages": "68-75", "score": 50057.7, "text_hl": "[Safety and Efficacy of @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@Amlodipine@@@, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@Rosuvastatin@@@ Therapy in @SPECIES_9606 @@@Patients@@@ With @<m>DISEASE_Metabolic_Syndrome</m> @DISEASE_MESH:D024821 @@@Metabolic Syndrome@@@ and @DISEASE_Non_alcoholic_Fatty_Liver_Disease @DISEASE_MESH:D065626 @@@Nonalcoholic Fatty Liver Disease@@@].", "citations": {"NLM": "Baranova EI, Berezina AV, Melioranskaya EI, Polyakova EA. [Safety and Efficacy of Amlodipine, Lisinopril and Rosuvastatin Therapy in Patients With Metabolic Syndrome and Nonalcoholic Fatty Liver Disease]. Kardiologiia. 2015 Oct;55(10):68-75. PMID: 28294798", "BibTeX": "@article{28294798, title={[Safety and Efficacy of Amlodipine, Lisinopril and Rosuvastatin Therapy in Patients With Metabolic Syndrome and Nonalcoholic Fatty Liver Disease].}, author={Baranova EI and Berezina AV and Melioranskaya EI and Polyakova EA}, journal={Kardiologiia}, volume={55}, number={10}, pages={68-75}}"}}]}